Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carnitine deficiency syndromes.

G N Breningstall1

  • 1Department of Pediatrics, Park Nicollet Medical Center, Minneapolis, Minnesota.

Pediatric Neurology
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Carnitine deficiency syndromes impair fatty acid metabolism, leading to energy failure in tissues. This results in metabolic disorders like encephalopathy, myopathy, and cardiomyopathy due to toxic fat accumulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality in pediatric epilepsy.

Pediatric neurology·2001
Same author

Intrauterine subdural hematoma.

Pediatric radiology·2000
Same author

Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children.

American heart journal·2000
Same author

An adolescent with complicated migraine.

Seminars in pediatric neurology·1999
Same author

An 11-year-old girl with syndrome of inappropriate antidiuretic hormone secretion.

Seminars in pediatric neurology·1999
Same author

Acute or subacute cranial computed tomography findings in patients with congenital lactic acidemia.

Clinical pediatrics·1999
Same journal

Corrigendum to Temporary Pacemaker in a Pediatric Guillain-Barré Case With Life-Threatening Bradyarrhythmia Pediatr Neurol 177 (2026) 109-110. doi: 10.1016/j.pediatrneurol.2026.01.015.

Pediatric neurology·2026
Same journal

Clinical Symptoms in Late Infantile and Juvenile Onset Neuronal Ceroid Lipofuscinosis Type 7 (CLN7 Disease).

Pediatric neurology·2026
Same journal

Examining Epilepsy in Angelman Syndrome: Insights From Caregiver-Reported Data in the Linking Angelman and Dup15q Data for Expanded Research Database.

Pediatric neurology·2026
Same journal

Impact of Postpandemic Pediatric Infection Rebound on Febrile Seizures: A Nationwide Cohort Study, 2013-2023.

Pediatric neurology·2026
Same journal

The Hidden Cost of Developmental and Epileptic Encephalopathy in Australia: Caregiver Quality of Life, Sleep, Depression, and Workforce Participation.

Pediatric neurology·2026
Same journal

A Novel Neonatal Brain Injury Score for Infants With Congenital Diaphragmatic Hernia.

Pediatric neurology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Genetics

Background:

  • Carnitine deficiency syndromes disrupt cellular energy production, primarily affecting tissues reliant on oxidative metabolism.
  • Impaired long-chain fatty acid metabolism leads to the accumulation of toxic fatty acyl derivatives.
  • This accumulation interferes with essential metabolic pathways like gluconeogenesis and the urea cycle.

Purpose of the Study:

  • To elucidate the clinical manifestations and underlying mechanisms of carnitine deficiency syndromes.
  • To differentiate between primary and secondary causes of systemic carnitine deficiency.
  • To highlight the role of carnitine transport in skeletal muscle function.

Main Methods:

  • Clinical case analysis of patients presenting with symptoms of carnitine deficiency.

Related Experiment Videos

  • Biochemical assays to assess fatty acid metabolism, carnitine levels, and acylcarnitine profiles.
  • Investigation of genetic and molecular factors contributing to carnitine transport defects.

    • Main Results:

    • Carnitine deficiency syndromes present with metabolic encephalopathy, myopathy, or cardiomyopathy.
    • Key biochemical findings include hypoketotic hypoglycemia, elevated transaminases, hyperammonemia, and dicarboxylic aciduria.
    • Defective carnitine transport into skeletal muscle characterizes myopathic carnitine deficiency.
    • Secondary deficiencies result from disorders promoting carnitine excretion, while primary deficiencies may stem from impaired renal conservation.

    Conclusions:

    • Carnitine deficiency syndromes represent a spectrum of metabolic disruptions with significant clinical impact.
    • Understanding the distinct causes, including transport defects and impaired renal conservation, is crucial for diagnosis and management.
    • Early identification and intervention are vital for tissues dependent on efficient oxidative metabolism.